While cell-to-cell variation in gene expression and receptor tyrosine kinase amplification within GBM are well recognized, it remains unclear how genetically and epigenetically distinct subpopulations contribute to variation in cell behavior. The gene discussed is NTRK1; the disease is glioblastoma.